WHO Schedules Emergency Meeting on Mpox Outbreak for November 22

The World Health Organization (WHO) has announced plans to convene its Emergency Committee next week. The meeting will assess whether mpox, previously declared a significant health concern, still qualifies as a global health emergency. This upcoming session underscores ongoing global vigilance as the virus continues to spread.

Mpox Designated a Public Health Emergency in Africa

In August, the WHO classified mpox as a Public Health Emergency of International Concern (PHEIC) due to the emergence of a new variant, clade Ib, spreading in various parts of Africa. This classification represents the highest alert level and emphasizes the importance of coordinated international efforts to monitor and control the outbreak.

Rising Cases and Fatalities in Africa

According to WHO’s latest report, Africa has seen a total of 46,794 confirmed and suspected mpox cases this year, with 1,081 deaths recorded as of November 3. The Democratic Republic of Congo has reported the highest number of cases, followed by Burundi and Uganda, reflecting the significant impact in these regions.

Symptoms and Transmission of Mpox

Mpox, typically spread through close physical contact, usually presents as a mild illness. Symptoms include flu-like signs along with painful, pus-filled lesions on the body. Although severe cases are rare, mpox can occasionally result in fatalities, highlighting the need for cautious monitoring and preventive measures.

Vaccine Allocations to Hard-Hit African Nations

This month, the initial doses of mpox vaccines were allocated to nine African countries that have been most affected by the outbreak. This effort aims to reduce the virus’s spread and offer protection to those in high-risk areas as WHO continues to address the health crisis.